Monoclonal antibodies capable of distinguishing epizootic from enzootic varieties of subtype 1 Venezuelan equine encephalitis viruses in a rapid indirect immunofluorescence assay.
We used previously characterized murine monoclonal antibodies to develop a panel useful in subtyping Venezuelan equine encephalitis (VEE) viruses by an indirect fluorescent antibody assay. This panel worked well with either prototype VEE viruses or a series of more recent VEE virus isolates. The panel is particularly useful for rapidly differentiating VEE viruses with epidemic-epizootic potential from other endemic varieties of this virus. Using this panel, we identified an antigenic variant of prototype VEE subtype 1E virus currently present in Mexico. This antigenic change in the E2 glycoprotein was confirmed by enzyme-linked immunosorbent assay. Because VEE virus virulence has been associated in part with the E2 glycoprotein, this observed antigenic change in the 1E virus E2 glycoprotein may explain the apparent equine virulence of this unusual VEE 1E virus.
Roehrig
J T
JT
National Center of Infectious Diseases, Centers for Disease Control and Prevention, U.S. Public Health Service, U.S. Department of Health and Human Services, Fort Collins, Colorado 80522, USA. jtr1@cidvbi1.em.cdc.gov
Bolin
R A
RA
D000818:Animals; D000911:Antibodies, Monoclonal / Q000276:immunology*; D000914:Antibodies, Viral / Q000276:immunology*; D004666:Encephalitis Virus, Venezuelan Equine / Q000276:immunology / Q000302:isolation & purification*; D004685:Encephalomyelitis, Venezuelan Equine / Q000821:virology*; D019084:Fluorescent Antibody Technique, Indirect / Q000379:methods*; D006736:Horses; D006801:Humans
D000911:Antibodies, Monoclonal; D000914:Antibodies, Viral